ADORX THERAPEUTICS LIMITED
- · Hygiene score: 70 → 90
- · Opportunity score: 64 → 72
- · Bankability: 75 → 85
- · Oldest live charge 8.4y old — refinance window within 12 months
Picture improved over the last 30 days — 3 positive signals vs 0 negative.
- ↑Opportunity score: 64 → 72
- ↑Hygiene score: 70 → 90
- ↑Bankability: 75 → 85
No snapshot from 90 days ago — start tracking from today.
No snapshot from 180 days ago — start tracking from today.
Opportunity 72/100 (strong), bankability 85/100. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Resolve: 1 insolvency-related filing on record. Filings relating to insolvency, liquidation, or administration exist in the company's history. Review before proceeding. Most likely exit: strategic trade sale (78/100).
Refinance opportunity
1 live charge · oldest 8.4y
Refinance conversation should be productive — structure clean and timing right.
- · Oldest live charge is 8.4 years old — likely at or near maturity.
- · Single lender — cleanest path to refinance.
- · Legal-friction score 15/100 — clean.
- · Profitable and stable/growing — lender coverage supportable.
Data confidence
Overall: medium (75/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Sector-multiple EBITDA, turnover, and NAV-proxy valuation range with confidence tier — derived from extracted iXBRL financials.
Available from the Pro tier upwards.
See pricing →Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · FRS 102Key financials
1 year extracted from filed iXBRL accountsFinancials
Extracted from Companies House accounts · FRS 102| Metric | 2025-02-28 |
|---|---|
| Profit before tax | £89.4k |
| Average employees | 0 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
Corporate timeline (29 events)Click to expand
- 2025-11-28📄accounts-with-accounts-type-fullaccounts · AA
- 2024-09-24📄accounts-with-accounts-type-fullaccounts · AA
- 2023-12-20📄memorandum-articlesincorporation · MA
- 2023-12-20📄resolutionresolution · RESOLUTIONS
- 2023-11-30📄accounts-with-accounts-type-smallaccounts · AA
- 2023-03-22📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC02
- 2023-03-21📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC05
- 2023-03-21📄capital-statement-capital-company-with-date-currency-figurecapital · SH19
- 2023-03-21📄legacycapital · SH20
- 2023-03-21⚠️legacyinsolvency · CAP-SS
- 2023-03-21📄resolutionresolution · RESOLUTIONS
- 2023-03-13📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC05
- 2023-03-10📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC05
- 2023-03-10📄termination-director-company-with-name-termination-dateofficers · TM01
- 2023-03-10📄appoint-person-director-company-with-name-dateofficers · AP01
- 2023-02-21➕SIRINAKIS, Kyparissia Katie appointeddirector
- 2023-02-21➖ROPER, Elizabeth Ann resigneddirector
- 2023-02-09📄capital-allotment-sharescapital · SH01
- 2022-11-15📄resolutionresolution · RESOLUTIONS
- 2022-11-15📄resolutionresolution · RESOLUTIONS
- 2022-11-15📄capital-variation-of-rights-attached-to-sharescapital · SH10
- 2022-11-15📄memorandum-articlesincorporation · MA
- 2022-09-22📄accounts-with-accounts-type-smallaccounts · AA
- 2018-03-19🔓Charge satisfied #1
- 2018-03-09➕MISCAMPBELL, Ian appointeddirector
- 2018-01-22🔒Charge registered #1Lender: Epidarex Capital Ii, LP
- 2017-02-24🏢Company incorporatedAs ADORX THERAPEUTICS LIMITED
- 2017-02-24➕FINAN, Peter Michael, Dr appointeddirector
- 2017-02-24➕ROPER, Elizabeth Ann appointeddirector
Owner dependency
Some founder dependency, but not acute. A structured handover period should cover most risk.
- +Senior director age: Director aged approximately 64 — approaching natural succession window.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primaryFounder aged 63+: Senior director is approximately 64. Approaching typical UK retirement age — succession thinking likely.
Red flags
1 high ·Filings relating to insolvency, liquidation, or administration exist in the company's history. Review before proceeding.
Evidence: 2023-03-21: legacy
Group structure
2 corporate shareholders identified. Group structure is distributed.
Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).
Shareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Epidarex Capital Partners Limited Corporate entity | 50–75% | 50–75% | board control50-75% shares · 50-75% voting · board control | 24/02/2017 |
Crt Pioneer Gp Limited Corporate entity | 25–50% | 25–50% | 25-50% shares · 25-50% voting | 09/03/2018 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Professional services · EH postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| CHARLES RIVER LABORATORIES EDINBURGH LIMITED→ SC091725 · est 1985 | £131.60M £96.97M–£166.24M | £135.39M | — | 135900 | 41y | 85 | 67y |
| ROBERTSON EDUCATION (ABERDEENSHIRE) HOLDINGS LIMITED→ SC209010 · est 2000 | £5.47M £4.03M–£6.91M | — | — | 0 | 25y | 85 | 60y |
| DSF (2003) LIMITED→ SC144009 · est 1993 | £4.70M £3.46M–£5.93M | — | — | 7 | 33y | 87 | 61y |
| FCC (EAST AYRSHIRE) HOLDINGS LIMITED→ SC300470 · est 2006 | £3.99M £2.94M–£5.03M | — | — | 0 | 20y | 87 | 60y |
| NWH HOLDINGS LIMITED→ SC303441 · est 2006 | £3.67M £2.70M–£4.64M | — | — | 373 | 19y | 88 | 61y |
| BLYTH & BLYTH CONSULTING ENGINEERS LIMITED→ SC241155 · est 2002 | £2.78M £2.05M–£3.52M | — | — | 93 | 23y | 87 | 85y |
| SIBCAS LIMITED→ SC052604 · est 1973 | £1.88M £1.39M–£2.38M | — | — | 165 | 53y | 88 | 68y |
| HORIZON (GP) LIMITED→ SC493523 · est 2014 | £45.2k £33.3k–£57.1k | — | — | 6 | 11y | 95 | 66y |
| BURNDENE INVESTMENTS LIMITED→ SC015613 · est 1929 | £14.3k £10.5k–£18.0k | — | — | 0 | 96y | 83 | 63y |
| 3 ED HOLDINGS 2 LIMITED→ SC328040 · est 2007 · no financials extracted | — | — | — | — | 18y | 83 | 65y |
| ABACUS FINANCIAL MARKETING LIMITED→ SC197503 · est 1999 | — | — | £3.4k | — | 26y | 83 | 59y |
| ACCOUNTING & TAXATION SERVICE LTD→ SC360357 · est 2009 · no financials extracted | — | — | — | — | 17y | 83 | 58y |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (3 active · 1 resigned)
Click a director name to see their full track record across all companies.
Mortgages & charges
| Type | Properties | |||||
|---|---|---|---|---|---|---|
| satisfied | Epidarex Capital Ii, LP | A registered charge | — | 22/01/2018 | 19/03/2018 |